November 21, 2024
Yanrui Song, Chenpan Nie, Tao Yang, Yinfei Yin, Henry Qixiang Li, Davy Xuesong Ouyang
Bioluminescent systemic xenograft models offer many advantages over conventional subcutaneous xenografts for hematological malignancy research and drug development. Systemic models recapitulate the disseminated progression of disease, and imaging allows real-time monitoring of disease progression and response to standard of care agents and cell therapies.
This poster details the generation of a panel of firefly luciferase (Luc) expressing hematologic xenograft models and presents initial tumor growth and treatment data.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-05-22
2021-10-26
landing_page
PDX/Databases